Many studies have shown that expression levels of PD-L2 are high in contrast to PD-L1 in multiple cancer types, including RCC [32], cervical cancer [33], and pancreatic ductal adenocarcinoma [34]. This evidence concerns the gene PDCD1LG2 and pancreatic ductal adenocarcinoma.